Profile data is unavailable for this security.
About the company
Aethlon Medical, Inc. is a clinical-stage medical device company. The Company is focused on advancing the Hemopurifier (HP), a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and organ transplantation and other areas of significant unmet needs. In pre-clinical studies, the Hemopurifier has exhibited the capacity to remove harmful extracellular vesicles (EVs) and enveloped viruses from biological fluids, utilizing its proprietary lectin-based mechanism. These extracellular vesicles have been implicated in disease processes such as immune suppression and metastasis in cancer as well as in the progression of severe life-threatening infectious diseases. The United States Food and Drug Administration (FDA) has designated the Hemopurifier as a Breakthrough Device for the treatment of individuals with advanced or metastatic cancer who are unresponsive to or intolerant of standard of care therapy.
- Revenue in USD (TTM)0.00
- Net income in USD-11.26m
- Incorporated1991
- Employees9.00
- LocationAethlon Medical Inc11555 Sorrento Valley Road, Suite 203SAN DIEGO 92121United StatesUSA
- Phone+1 (619) 941-0360
- Fax+1 (619) 941-0361
- Websitehttps://www.aethlonmedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Leafbuyer Technologies Inc | 5.84m | 205.18k | 1.20m | 12.00 | 5.85 | -- | -- | 0.2058 | 0.002 | 0.002 | 0.0583 | -0.0142 | 6.35 | -- | 71.02 | 486,275.00 | 22.33 | -44.28 | -- | -- | 44.04 | 37.83 | 3.52 | -21.61 | -- | 3.07 | -- | -- | 15.54 | 20.68 | 136.74 | -27.51 | -- | -- |
| Sigyn Therapeutics Inc | 0.00 | -3.22m | 1.20m | 4.00 | -- | -- | -- | -- | -2.01 | -2.01 | 0.00 | -3.69 | 0.00 | -- | -- | 0.00 | -1,144.23 | -590.29 | -- | -- | -- | -- | -- | -- | -- | -3.44 | -- | -- | -- | -- | 19.43 | -- | -- | -- |
| Zynex Inc | 108.20m | -73.96m | 1.22m | 1.00k | -- | -- | -- | 0.0112 | -2.43 | -2.43 | 3.49 | -1.34 | 1.26 | 2.20 | 7.64 | 108,202.00 | -86.31 | 10.48 | -203.55 | 12.42 | 71.90 | 79.57 | -68.35 | 7.51 | 0.3174 | -12.22 | 3.19 | -- | 4.36 | 33.44 | -69.24 | -20.61 | 29.29 | -- |
| Nu-Med Plus Inc | 0.00 | -54.13k | 1.28m | 2.00 | -- | -- | -- | -- | -0.0006 | -0.0006 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -910.51 | -451.95 | -- | -- | -- | -- | -- | -- | -- | -8.61 | -- | -- | -- | -- | 45.55 | -- | -- | -- |
| Escalon Medical Corp | 11.94m | -200.38k | 1.43m | 39.00 | -- | 1.39 | -- | 0.1202 | -0.0436 | -0.0436 | 1.11 | 0.2259 | 2.57 | 3.67 | 7.31 | 306,156.90 | -2.20 | 1.53 | -4.99 | 3.48 | 45.38 | 43.87 | -0.8552 | 0.7026 | 0.979 | -1.96 | 0.1335 | -- | 0.5395 | 5.09 | 115.88 | -- | -42.12 | -- |
| Aethlon Medical Inc | 0.00 | -11.26m | 1.93m | 9.00 | -- | 0.2623 | -- | -- | -56.69 | -56.69 | 0.00 | 7.55 | 0.00 | -- | -- | 0.00 | -139.25 | -86.44 | -181.09 | -98.06 | -- | -- | -- | -3,662.04 | -- | -- | 0.00 | -- | -- | -- | -9.67 | -- | -- | -- |
| Tivic Health Systems Inc | 482.00k | -7.51m | 2.05m | 7.00 | -- | 0.2409 | -- | 4.24 | -9.87 | -9.87 | 0.5914 | 3.36 | 0.1002 | 2.07 | 34.43 | 68,857.14 | -156.00 | -118.40 | -178.18 | -148.80 | -58.09 | 5.50 | -1,557.26 | -610.99 | 5.86 | -- | 0.00 | -- | -33.67 | 13.18 | 31.40 | -- | -- | -- |
| Agape ATP Corp | 1.48m | -2.71m | 2.08m | 16.00 | -- | 0.0911 | -- | 1.40 | -14.97 | -14.97 | 2.61 | 22.83 | 0.1047 | 13.99 | 60.14 | 92,806.88 | -19.46 | -34.76 | -21.27 | -44.44 | 52.68 | 69.19 | -185.74 | -92.86 | 16.18 | -- | 0.0056 | -- | -7.57 | -- | -17.53 | -- | -- | -- |
| Catheter Precision Inc | 730.00k | -22.19m | 2.12m | 22.00 | -- | 0.3084 | -- | 2.90 | -37.38 | -37.38 | 0.9371 | 4.12 | 0.028 | 1.64 | 6.35 | 33,181.82 | -66.93 | -128.03 | -78.29 | -160.12 | 92.60 | -242.70 | -2,393.84 | -15,268.88 | 0.4569 | -66.84 | 0.0449 | -- | -4.98 | -19.89 | 69.45 | -- | -24.21 | -- |
| STRATA Skin Sciences Inc | 30.98m | -11.04m | 2.30m | 106.00 | -- | 1.56 | -- | 0.0741 | -2.62 | -2.62 | 7.29 | 0.2494 | 0.8736 | 4.51 | 7.80 | 292,264.20 | -31.13 | -14.64 | -52.77 | -21.51 | 57.76 | 59.75 | -35.64 | -21.51 | 0.746 | -4.02 | 0.921 | -- | 0.6116 | 1.22 | 6.87 | -- | -10.13 | -- |
| INVO Fertility Inc | 6.94m | -27.13m | 2.48m | 28.00 | -- | -- | -- | 0.3575 | -602.89 | -644.67 | 50.02 | 8.63 | 0.3874 | 19.50 | 26.14 | 247,996.40 | -149.96 | -63.14 | -299.48 | -98.96 | 39.17 | 60.46 | -387.11 | -276.30 | 0.1022 | -10.36 | 0.2530 | -- | 116.25 | 34.57 | -16.33 | -- | 9.88 | -- |
| Work Medical Technology Group Ltd | 10.74m | -3.71m | 2.67m | 229.00 | -- | 0.0002 | -- | 0.2489 | -2,871.58 | -2,871.58 | 7,811.59 | 8,868.19 | -- | -- | -- | 46,903.67 | -- | -- | -- | -- | 26.89 | -- | -35.42 | -- | 0.9802 | -8.87 | 0.4505 | -- | -15.18 | -- | -3,217.31 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Aethlon Medical Inc's reporting currency: US Dollar USD
6.81%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Ikarian Capital LLCas of 30 Sep 2025 | 15.37k | 2.02% |
| HRT Financial LPas of 30 Sep 2025 | 13.06k | 1.72% |
| Citadel Securities LLCas of 30 Sep 2025 | 9.51k | 1.25% |
| Renaissance Technologies LLCas of 30 Sep 2025 | 4.60k | 0.60% |
| Scientech Research LLCas of 30 Sep 2025 | 2.60k | 0.34% |
| Two Sigma Investments LPas of 30 Sep 2025 | 2.03k | 0.27% |
| XTX Markets LLCas of 30 Sep 2025 | 1.55k | 0.20% |
| Two Sigma Securities LLCas of 30 Sep 2025 | 1.47k | 0.19% |
| Geode Capital Management LLCas of 30 Sep 2025 | 1.35k | 0.18% |
| Tower Research Capital LLCas of 30 Sep 2025 | 299.00 | 0.04% |
More ▼
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
